| Daniel Situ, OD | |
|
100 Battery St, San Francisco, CA 94111-4903 | |
| (415) 399-1573 | |
| Not Available |
| Full Name | Daniel Situ |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 100 Battery St, San Francisco, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003265877 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT33422 (California) | Primary |
| Provider Name | Stamper Optometry Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437241833 PECOS PAC ID: 2365420213 Enrollment ID: O20040708000858 |
News Archive
Researchers at Children's Hospital Boston have developed a slow-release anesthetic drug-delivery system that could potentially revolutionize treatment of pain during and after surgery, and may also have a large impact on chronic pain management.
WHO urges affected countries to scale up their investment in tackling 17 neglected tropical diseases in order to improve the health and well-being of more than 1.5 billion people. This investment would represent as little as 0.1% of current domestic expenditure on health in affected low and middle income countries for the period 2015-2030.
BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.
Two specific genetic variations in people of African descent are responsible for persistent atopic dermatitis (AD), an itchy, inflammatory form of the skin disorder eczema. A new report by researchers in the Perelman School of Medicine at the University of Pennsylvania found that loss-of-function mutations to Filaggrin-2 (FLG2), a gene that creates a protein responsible for retaining moisture and protecting the skin from environmental irritants, were associated with atopic dermatitis in African American children.
Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Situ, OD 2508 Mission St, San Francisco, CA 94110-2512 Ph: () - | Daniel Situ, OD 100 Battery St, San Francisco, CA 94111-4903 Ph: (415) 399-1573 |
News Archive
Researchers at Children's Hospital Boston have developed a slow-release anesthetic drug-delivery system that could potentially revolutionize treatment of pain during and after surgery, and may also have a large impact on chronic pain management.
WHO urges affected countries to scale up their investment in tackling 17 neglected tropical diseases in order to improve the health and well-being of more than 1.5 billion people. This investment would represent as little as 0.1% of current domestic expenditure on health in affected low and middle income countries for the period 2015-2030.
BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.
Two specific genetic variations in people of African descent are responsible for persistent atopic dermatitis (AD), an itchy, inflammatory form of the skin disorder eczema. A new report by researchers in the Perelman School of Medicine at the University of Pennsylvania found that loss-of-function mutations to Filaggrin-2 (FLG2), a gene that creates a protein responsible for retaining moisture and protecting the skin from environmental irritants, were associated with atopic dermatitis in African American children.
Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.
› Verified 2 days ago
Jennifer Elizabeth Ding, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2007 Irving St, San Francisco, CA 94122 Phone: 415-564-1818 | |
Opt Optometric Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1415 Valencia St, San Francisco, CA 94110 Phone: 415-572-5500 | |
Geri Cheng, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3518 Balboa St, San Francisco, CA 94121 Phone: 415-386-3937 | |
Bruce Gary Dong, OPTOMETRIST Optometrist Medicare: Not Enrolled in Medicare Practice Location: 619 Irving St, San Francisco, CA 94122 Phone: 415-661-8253 Fax: 415-661-2490 | |
Philip Tawil, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2049 Oak St Apt 1, San Francisco, CA 94117 Phone: 415-431-2988 | |
Leona Landers, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 Howard St, Suite B, San Francisco, CA 94105 Phone: 415-908-2733 |